Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 4/20 | 0.73 |
| ▸ | FAAH | O00519 | 2/20 | 0.63 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.62 |
| ▸ | HPGD | P15428 | 2/20 | 0.60 |
| ▸ | CNR1 | P21554 | 2/20 | 0.60 |
| ▸ | CNR2 | P34972 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | STS | P08842 | 1/20 | 0.59 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.58 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.58 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3809498 | 0.89 | EPHX2 (0.84) | EPHX2FAAHTRPV1HPGDCNR1 | |
| SCHEMBL4970472 | 0.85 | EPHX2 (0.61) | EPHX2FAAHTRPV1HPGDCNR1 | |
| SCHEMBL29052372 | 0.84 | EPHX2 (1.00) | EPHX2FAAHTRPV1HPGDCNR1 | |
| SCHEMBL5696750 | 0.84 | EPHX2 (1.00) | EPHX2FAAHTRPV1HPGDCNR1 | |
| SCHEMBL5471650 | 0.84 | EPHX2 (1.00) | EPHX2FAAHTRPV1HPGDCNR1 | |
| Nonanoic Acid Benzylamide SCHEMBL3280214 | 0.84 | EPHX2 (1.00) | EPHX2FAAHTRPV1HPGDCNR1 | |
| N-Benzyldodecanamide SCHEMBL3977374 | 0.84 | EPHX2 (1.00) | EPHX2FAAHTRPV1HPGDCNR1 | |
| SCHEMBL16714726 | 0.84 | EPHX2 (1.00) | EPHX2FAAHTRPV1HPGDCNR1 | |
| SCHEMBL2524088 | 0.84 | EPHX2 (1.00) | EPHX2FAAHTRPV1HPGDCNR1 | |
| SCHEMBL2166861 | 0.84 | EPHX2 (1.00) | EPHX2FAAHTRPV1HPGDCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200148937-A1 | INHIBITING HYDROCARBON HYDRATE AGGLOMERATION | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2020-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200148937-A1 | INHIBITING HYDROCARBON HYDRATE AGGLOMERATION | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AHR, SHH | EPHX2 2131/4885FAAH 376/4885TRPV1 368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.